Dio

Dio Financial Leverage

The Financial Leverage (Equity Multiplier) of Dio (039840.KQ) as of Oct 19, 2026 is 1.71. In the previous year, Financial Leverage (Equity Multiplier) was 1.68 — a change of 1.88% (higher).

Financial Leverage

1.71

YoY

1.88%

Last updated:

Financial Leverage (Equity Multiplier) of Dio is 2025 1.71 . Financial Leverage (Equity Multiplier) of Dio was 2024 1.68 . It decreases by 1.88% higher compared to the previous year.

The Dio Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.98 KRW
Jan 1, 2019
1.92 KRW
Jan 1, 2020
2.00 KRW
Jan 1, 2021
1.86 KRW
Jan 1, 2022
1.99 KRW
Jan 1, 2023
1.89 KRW
Jan 1, 2024
1.68 KRW
Jan 1, 2025
1.71 KRW
The Dio Financial Leverage history
YEARFinancial LeverageYoY
1.71+1.88%
1.68-11.04%
1.89-5.06%
1.99+6.96%
1.86-7.10%
2.00+4.49%
1.92-3.24%
1.98+23.74%
1.60+13.76%
1.41-10.54%
1.57-47.57%
3.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dio Stock analysis

What does Dio do? Dio Corp, listed on the Korean stock exchange with ticker 039840.KQ and ISIN KR7039840004, is headquartered in Busan, South Korea. The company operates in the Health Care sector, specifically within the Health Care industry. Dio Corp employs 468 full-time staff and went public on June 29, 2000. The company's website is https://www.dio.co.kr/kor/intro.do. Dio Corp manufactures and sells medical devices, with operations structured across two divisions. The medical equipment division offers dental implant systems, surface treatment products, surgical instruments, and oral care products including whitening foam toothpastes, children's foam toothpastes, and foam cleansers. Additionally, this division provides digital imaging systems, dental lasers, dental equipment, implant devices, and dental materials. The parking system division focuses on parking systems and steel structures for buildings. Dio Corp distributes its products both domestically within South Korea and internationally. The company's business activities are centered on medical device manufacturing and related services, with a presence in both domestic and overseas markets. No additional details about founding year, specific acquisitions, or financial figures beyond the provided employee count and IPO date are available from the source material. Dio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dio stock

Financial Leverage (Equity Multiplier) of Dio is 1.71 in 2025.

Financial Leverage (Equity Multiplier) of Dio changed from 1.68 to 1.71, representing a 1.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Dio since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Dio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Dio

All Key Metrics — Dio